Click image to enlarge
The R-PLEX platform offers both antibody sets and assays for a wide menu of biomarkers. The R-PLEX Mouse VEGFR-1/Flt-1 Assay has the essential components to build an assay that measures VEGFR-1/Flt-1 in a single analyte format. For information on multiplexing VEGFR-1/Flt-1 with other analytes, please see the
R-PLEX Mouse VEGFR-1/Flt-1 Antibody Set.
The Product Insert for R-PLEX Assays provides detailed instructions for building a singleplex assay. The datasheet for Mouse VEGFR-1/Flt-1 provides information on the components (including calibrator stock concentration), recommended sample types and dilution factors, and representative data for analytical performance. These items and other helpful documents can be found in the "Documentation" tab below.
Related Key Termsvascular endothelial growth factor receptor-1, sVEGFR-1, FLT, FLT-1, FMS-like tyrosine kinase 1
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Growth Factors
,
Oncology & Cancer
,
Cardiovascular
|
|
|
Analyte(s)
|
|
VEGFR-1/Flt-1
|
|
|
Species
|
|
Mouse
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
|
Plate Type
|
|
96-well
|
|
|
LLOD (Sensitivity)
|
|
145 pg/mL
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
14254
|
|
|
UniProt ID(s)
|
|
P35969
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Mouse VEGFR-1/Flt-1 Antibody Set
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
Mouse VEGFR-1/Flt-1 Calibrator
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 each
(1 plate)
|
|
|
|
|
2-8 °C
|
1 bottle
(50 mL)
|
|
|
|
|
≤-10 °C
|
1 bottle
(50 mL)
|
|
|
|
|
≤-10 °C
|
1 bottle
(50 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Handouts
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
|
|
|
|
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2 in patients with advanced hepatocellular cancer.
|
|
|
|
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.
|
|
|
|
Elevated sputum Interleukin-5 and submucosal eosinophilia in obese severe asthmatics.
|
|
|
|
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea
|
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters